Literature DB >> 15466998

Fibrinolytic activity in Nigerian diabetics.

I A Adediran1, R T Ikem, M F Borisade.   

Abstract

Fibrinolytic activity, using euglobulin lysis time (ELT), was assessed in 46 Nigerians with type 2 diabetes mellitus to study the effect of the disease on fibrinolytic component of haemostasis. There were 20 females and 26 males. Fifty age matched non-diabetics and apparently healthy Nigerians were similarly studied as controls; there were 24 females and 26 males. In the patients, the mean (SD) age of the females was 56.7 (12.0) years and mean (SD) ELT was 276.4 (62.2) min; the mean age of the males was 55.7 (8.5) years and mean ELT was 303.5 (51.5) min. The mean age for female controls was 54.3 (12.6) years and their mean ELT was 198.3 (37.5) min; the mean age of the male controls was 53.4 (11.0) years and mean ELT was 181.6 (39.4) min. There was reduced fibrinolytic activity in diabetic Nigerians as revealed by significantly prolonged ELT in diabetic patients compared with healthy controls. There was good correlation between the blood glucose level and ELT. The observed changes in fibrinolytic activity in this study were not affected by duration of illness. The prolonged ELT in the diabetic population is an additional risk factor for thromboembolic disorders. Fibrinolytic agents may therefore be useful in the management of diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15466998      PMCID: PMC1743117          DOI: 10.1136/pgmj.2003.017996

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  20 in total

1.  THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE.

Authors:  F K BELLER; U GOEBELSMANN; G W DOUGLAS; A JOHNSON
Journal:  Obstet Gynecol       Date:  1964-01       Impact factor: 7.661

2.  Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.

Authors:  J Auwerx; R Bouillon; D Collen; J Geboers
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

Review 3.  Platelet dysfunction in type 2 diabetes.

Authors:  A I Vinik; T Erbas; T S Park; R Nolan; G L Pittenger
Journal:  Diabetes Care       Date:  2001-08       Impact factor: 19.112

4.  Enhanced fibrinolysis in Nigerians--probable contributory factor to low prevalence of atherosclerosis in the Nigerian.

Authors:  E M Essien
Journal:  Afr J Med Med Sci       Date:  1976-12

Review 5.  Factors of the hemostatic system in diabetic patients. A survey of controlled studies.

Authors:  H Ostermann; J van de Loo
Journal:  Haemostasis       Date:  1986

6.  A comparative study of coagulation and fibrinolysis in blood from normal men and women.

Authors:  P Brakman; O K Albrechtsen; T Astrup
Journal:  Br J Haematol       Date:  1966-01       Impact factor: 6.998

7.  Platelet function, factor VIII, fibrinogen, and fibrinolysis in Nigerians and Europeans in relation to atheroma and thrombosis.

Authors:  E Dupuy; A F Fleming; J P Caen
Journal:  J Clin Pathol       Date:  1978-11       Impact factor: 3.411

8.  Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations.

Authors:  T W Meade; R Chakrabarti; A P Haines; W R North; Y Stirling
Journal:  Br Med J       Date:  1979-01-20

9.  Effect of age, sex, and diurnal variation on the human fibrinolystic system.

Authors:  R D Mann
Journal:  J Clin Pathol       Date:  1967-05       Impact factor: 3.411

10.  Is red cell sorbitol content a good marker of glycemic control in diabetic patients?

Authors:  A Lapolla; T Poli; A Valerio; D Fedele
Journal:  Diabetes Res       Date:  1985-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.